Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial.
Guerdjikova, Anna I; Mori, Nicole; Blom, Thomas J; Keck, Paul E; Williams, Stephanie L; Welge, Jeffrey A; McElroy, Susan L.
; 31(5): 382-91, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27650406
Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder.
A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults.
Lisdexamfetamine: A Review in Binge Eating Disorder.
Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.
Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence.
Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.
Methylphenidate Overdose Causing Secondary Polydipsia and Severe Hyponatremia in an 8-Year-Old Boy.
Efficacy and tolerability of lisdexamfetamine as an antidepressant augmentation strategy: A meta-analysis of randomized controlled trials.
Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder.